Has Tina Hill received payments from drug or device companies?

Yes. Drug and device makers reported $1,453 in general payments to Tina Hill across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tina Hill did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tina Hill come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tina Hill

Family · Blue Springs, MONPI 1316530835

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $836 and has fallen 96.0% since, to $33 in 2024.

$1,453in general payments, 2019–2025

Across 85 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$190
Lilly USA, LLC$141
Merck$120
Novo Nordisk$96
Dexcom, Inc.$92
Axsome Therapeutics, Inc.$81
plus $733 from 22 others

What the payments were for

Food & beverage$1,453100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	11	$190
Lilly USA, LLC	8	$141
Merck	7	$120
Novo Nordisk	5	$96
Dexcom, Inc.	6	$92
Axsome Therapeutics, Inc.	5	$81
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$80
Bayer	5	$79
Otsuka America Pharmaceutical, Inc.	4	$76
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$56
Teva Pharmaceuticals USA, Inc.	3	$50
Boehringer Ingelheim	3	$49
Daiichi Sankyo Inc.	2	$44
Corcept Therapeutics	2	$41
GSK	2	$29
QOL Medical, LLC	1	$27
Amgen	2	$27
AstraZeneca	1	$20
Ironwood Pharmaceuticals, Inc	1	$19
Novartis	1	$17
Sanofi-aventis U.S. LLC	1	$16
Johnson & Johnson	1	$16
GRT US Holding, Inc.	1	$16
Pfizer	1	$16
IBSA Pharma Inc.	1	$14
Collegium Pharmaceutical, Inc.	1	$14
Kowa Pharmaceuticals America, Inc.	1	$13
Mylan Specialty L.p.	1	$13

How this compares

$1,453 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ProgesteroneProgesterone, Micronized	27	$1,056

Paid to pharmacies, not to this prescriber.

Other family in Blue Springs

Erica GormanBlue Springs$14K
Shayla SandersKansas City$306K
Tamera WolfLees Summit$215K
Tiffany ArnoldFestus$177K
Tiffany NelsonSedalia$164K
Chelsey BeckerSaint Peters$104K
Carey PattonDes Peres$94K
Marcy MarkesColumbia$92K
Laura HedigerSpringfield$71K
Rebecca SeabaughSaint Louis$68K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →